Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Share (Tables)

v3.20.2
Net Loss Per Share (Tables)
9 Months Ended
Sep. 30, 2020
Net Loss Per Share  
Schedule of antidilutive securities

We had securities which could potentially dilute basic earnings per share, but were excluded from the computation of diluted loss per share for all periods presented, as their effect would have been antidilutive. These securities consist of the following (in thousands):

Three Months Ended 

Nine Months Ended 

 

September 30, 

September 30, 

2020

    

2019

2020

    

2019

 

Outstanding stock options

27,646

22,665

27,646

22,665

Purchase Plan

59

125

59

125

Total

27,705

22,790

27,705

22,790